rs3741918
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002046.7(GAPDH):c.29+229T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 759,242 control chromosomes in the GnomAD database, including 16,848 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 3655 hom., cov: 33)
Exomes 𝑓: 0.20 ( 13193 hom. )
Consequence
GAPDH
NM_002046.7 intron
NM_002046.7 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.660
Publications
8 publications found
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.362 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.215 AC: 32704AN: 152024Hom.: 3649 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
32704
AN:
152024
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.201 AC: 122172AN: 607098Hom.: 13193 Cov.: 8 AF XY: 0.197 AC XY: 60628AN XY: 308154 show subpopulations
GnomAD4 exome
AF:
AC:
122172
AN:
607098
Hom.:
Cov.:
8
AF XY:
AC XY:
60628
AN XY:
308154
show subpopulations
African (AFR)
AF:
AC:
2649
AN:
12162
American (AMR)
AF:
AC:
2910
AN:
13390
Ashkenazi Jewish (ASJ)
AF:
AC:
1225
AN:
13288
East Asian (EAS)
AF:
AC:
8050
AN:
25784
South Asian (SAS)
AF:
AC:
5144
AN:
43102
European-Finnish (FIN)
AF:
AC:
6400
AN:
27818
Middle Eastern (MID)
AF:
AC:
209
AN:
2302
European-Non Finnish (NFE)
AF:
AC:
89585
AN:
439028
Other (OTH)
AF:
AC:
6000
AN:
30224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4527
9054
13581
18108
22635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2152
4304
6456
8608
10760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.215 AC: 32725AN: 152144Hom.: 3655 Cov.: 33 AF XY: 0.213 AC XY: 15868AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
32725
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
15868
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
9327
AN:
41532
American (AMR)
AF:
AC:
3327
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
304
AN:
3468
East Asian (EAS)
AF:
AC:
1940
AN:
5156
South Asian (SAS)
AF:
AC:
601
AN:
4826
European-Finnish (FIN)
AF:
AC:
2423
AN:
10606
Middle Eastern (MID)
AF:
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14186
AN:
67944
Other (OTH)
AF:
AC:
399
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1351
2703
4054
5406
6757
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
841
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.